| Literature DB >> 18583939 |
Gustavo Palacios1, Flaminia Talos, Alice Nemajerova, Ute M Moll, Oleksi Petrenko.
Abstract
To better understand the role of E2F1 in tumor formation, we analyzed spontaneous tumorigenesis in p53(-/-)E2F1(+/+) and p53(-/-)E2F1(-/-) mice. We show that the combined loss of p53 and E2F1 leads to an increased incidence of sarcomas and carcinomas compared to the loss of p53 alone. E2F1-deficient tumors show wide chromosomal variation, indicative of genomic instability. Consistent with this, p53(-/-)E2F1(-/-) primary fibroblasts have a reduced capacity to maintain genomic stability when exposed to S-phase inhibitors or genotoxic drugs. A major mechanism of E2F1's contribution to genomic integrity lies in mediating stabilization and engagement of the Rb protein.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18583939 PMCID: PMC4012429 DOI: 10.4161/cc.7.12.6030
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 4.534